NYSEMKT: AEON
Aeon Biopharma Inc Stock Ownership - Who owns Aeon Biopharma?

Insider buying vs selling

Have Aeon Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jost FischerDirector2025-05-2160,000$0.49
$29.22kBuy
Jost FischerDirector2025-05-2060,000$0.51
$30.36kBuy
Jost FischerDirector2025-05-1950,000$0.50
$24.95kBuy

1 of 1

AEON insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AEON insiders and whales buy or sell their stock.

AEON Shareholders

What type of owners hold Aeon Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Priveterra Sponsor LLC1,192.84%13,889,163$11.72MInsider
Daewoong Co Ltd564.90%6,577,604$5.55MInsider
Robert J. Palmisano197.62%2,301,021$1.94MInsider
Strathspey Crown Holdings Group LLC174.49%2,031,773$1.71MInsider
Dauntless Investment Group LLC96.62%1,125,000$949.50kInstitution
Marc Forth64.46%750,547$633.46kInsider
Barclays PLC60.35%702,645$593.03kInsider
Chad Oh25.12%292,545$246.91kInsider
Jost Fischer22.91%266,785$225.17kInsider
Alexander Blair Wilson22.46%261,538$220.74kInsider

1 of 3

AEON vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AEON4.44%95.56%Net Buying
CDT0.03%99.97%Net BuyingNet Buying
OGEN0.26%99.74%Net Selling
ENVB30.06%69.94%
REVB1.02%98.98%Net BuyingNet Buying

Aeon Biopharma Stock Ownership FAQ

Who owns Aeon Biopharma?

Aeon Biopharma (NYSEMKT: AEON) is owned by 109.18% institutional shareholders, 2,348.10% Aeon Biopharma insiders, and 0.00% retail investors. Priveterra Sponsor LLC is the largest individual Aeon Biopharma shareholder, owning 13.89M shares representing 1,192.84% of the company. Priveterra Sponsor LLC's Aeon Biopharma shares are currently valued at $11.81M.

If you're new to stock investing, here's how to buy Aeon Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.